Clinical characteristics of patients with repeated systemic reactions during specific immunotherapy with hymenoptera venoms
- 1 May 1991
- Vol. 46 (4) , 251-254
- https://doi.org/10.1111/j.1398-9995.1991.tb00582.x
Abstract
In general, specific immunotherapy with hymenoptera venoms can be considered as safe, but occasionally there are patients who cannot reach the maintenance dose due to repeated systemic reactions (RSR) or who suffer from RSR during maintenance therapy. In a multicenter retrospective study comprising seven departments in Germany, Austria and Switzerland 23 patients with RSR were reported from approximately 3000 patients treated with hymenoptera venoms (bee and wasp venom to approximately equivalent frequency). From these, 22 were allergic to bee venom and only one to vespid venom. In general the clinical symptoms of RSR were milder than the initial reaction. But 4/23 (18%) exhibited cardiovascular reactions up to full shock. Neither anamnestic details, reactivity in skin tests or in vitro tests revealed a special pattern of patients with RSR. In some patients, however, an extremely high reactivity in the skin test was found and may indicate the possibility of further RSR.Keywords
This publication has 6 references indexed in Scilit:
- Fatalities from immunotherapy (IT) and skin testing (ST)Journal of Allergy and Clinical Immunology, 1987
- Schnellhyposensibilisierung mit Hymenopterengiften: Verträglichkeit und TherapieerfolgDeutsche Medizinische Wochenschrift (1946), 1987
- 412 Combined active and passive immunotherapy in honey bee sting allergyJournal of Allergy and Clinical Immunology, 1985
- Venom Immunotherapy in Hymenoptera Sting AllergyAllergy, 1983
- Antibodies to purified bee venom proteins and peptides II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigensJournal of Allergy and Clinical Immunology, 1983
- INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTESPublished by Elsevier ,1977